Ha habido 50 transacciones internas recientes registradas para Mind Medicine (MindMed) Inc. (MNMD), incluyendo 26 compras y 22 ventas. El total de compras internas fue valorado en $14.47M y el total de ventas internas en $1.75M.
Internos destacados con actividad reciente incluyen Sullivan Mark, Barrow Robert, Karlin Daniel. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — MNMD
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-06-25 |
Sullivan Mark |
Chief Legal Officer |
Venta Informativa |
11,491 |
$6.80 |
$78.14K |
305,130 |
| 2025-06-25 |
Barrow Robert |
Chief Executive Officer |
Venta Informativa |
26,491 |
$6.80 |
$180.14K |
830,065 |
| 2025-06-25 |
Karlin Daniel |
Chief Medical Officer |
Venta Informativa |
7,848 |
$6.80 |
$53.37K |
438,329 |
| 2025-06-12 |
Gryska David W |
Director |
Concesión de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Vallone Carol A |
Director |
Concesión de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Krebs Andreas |
Director |
Concesión de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Bruhn Suzanne Louise |
Director |
Concesión de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Crystal Roger |
Director |
Concesión de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-02 |
Roberts Brandi |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-06-02 |
Roberts Brandi |
Chief Financial Officer |
Concesión de RSU |
500,000 |
$7.26 |
$3.63M |
500,000 |
| 2025-03-25 |
Sullivan Mark |
Chief Legal Officer |
Venta Informativa |
6,576 |
$6.74 |
$44.32K |
316,621 |
| 2025-03-25 |
Barrow Robert |
Chief Executive Officer |
Venta Informativa |
21,208 |
$6.74 |
$142.94K |
856,556 |
| 2025-03-25 |
Karlin Daniel |
Chief Medical Officer |
Venta Informativa |
6,836 |
$6.74 |
$46.07K |
446,177 |
| 2025-03-25 |
Liao Carrie |
Chief Accounting Officer |
Venta Informativa |
2,347 |
$6.74 |
$15.82K |
144,923 |
| 2025-03-17 |
Wiley Matthew T. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-03-17 |
Wiley Matthew T. |
Chief Commercial Officer |
Concesión de RSU |
350,000 |
$6.35 |
$2.22M |
350,000 |
| 2025-03-12 |
Sullivan Mark |
Chief Legal Officer |
Concesión de RSU |
150,000 |
- |
- |
323,197 |
| 2025-03-12 |
Barrow Robert |
Chief Executive Officer |
Concesión de RSU |
350,000 |
- |
- |
877,764 |
| 2025-03-12 |
Karlin Daniel |
Chief Medical Officer |
Concesión de RSU |
115,000 |
- |
- |
453,013 |
| 2025-03-12 |
Liao Carrie |
Chief Accounting Officer |
Concesión de RSU |
50,000 |
- |
- |
142,270 |
| 2024-12-26 |
Sullivan Mark |
Chief Legal Officer |
Venta Informativa |
4,519 |
$7.43 |
$33.58K |
173,197 |
| 2024-12-26 |
Barrow Robert |
Chief Executive Officer |
Venta Informativa |
19,106 |
$7.43 |
$141.96K |
526,666 |
| 2024-12-26 |
Karlin Dan |
Chief Medical Officer |
Venta Informativa |
6,643 |
$7.43 |
$49.36K |
338,013 |
| 2024-12-26 |
Liao Carrie |
Chief Accounting Officer |
Venta Informativa |
2,273 |
$7.43 |
$16.89K |
97,270 |
| 2024-12-05 |
Gryska David W |
Director |
Compra Informativa |
2,500 |
$7.17 |
$17.93K |
19,851 |
| 2024-09-25 |
Sullivan Mark |
Chief Legal Officer |
Venta Informativa |
4,430 |
$5.98 |
$26.49K |
177,716 |
| 2024-09-25 |
Barrow Robert |
Chief Executive Officer |
Venta Informativa |
19,771 |
$5.98 |
$118.23K |
545,772 |
| 2024-09-25 |
Karlin Dan |
Chief Medical Officer |
Venta Informativa |
6,871 |
$5.98 |
$41.09K |
344,656 |
| 2024-09-25 |
Liao Carrie |
Chief Accounting Officer |
Venta Informativa |
2,352 |
$5.98 |
$14.06K |
99,543 |
| 2024-08-23 |
Gryska David W |
Director |
Compra Informativa |
3,500 |
$5.98 |
$20.93K |
17,351 |
| 2024-08-21 |
Halperin Wernli Miri |
Executive President |
Ejercicio de Opciones (Venta) |
50,000 |
$3.70 |
$185K |
- |
| 2024-08-20 |
Barrow Robert |
Chief Executive Officer |
Compra Informativa |
500 |
$6.12 |
$3.06K |
565,543 |
| 2024-08-19 |
Barrow Robert |
Chief Executive Officer |
Compra Informativa |
500 |
$6.31 |
$3.16K |
565,043 |
| 2024-06-25 |
Sullivan Mark |
Chief Legal Officer |
Venta Informativa |
17,854 |
$7.22 |
$128.91K |
182,146 |
| 2024-06-25 |
Barrow Robert |
Chief Executive Officer |
Venta Informativa |
15,659 |
$7.22 |
$113.06K |
564,543 |
| 2024-06-25 |
Karlin Dan |
Chief Medical Officer |
Venta Informativa |
6,925 |
$7.22 |
$50K |
351,527 |
| 2024-06-10 |
Gryska David W |
Director |
Concesión de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Vallone Carol A |
Director |
Concesión de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Krebs Andreas |
Director |
Concesión de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Bruhn Suzanne Louise |
Director |
Concesión de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Crystal Roger |
Director |
Concesión de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-03-25 |
Greenway Schond L. |
Chief Financial Officer |
Retención Fiscal de RSU |
5,560 |
$9.78 |
$54.38K |
211,057 |
| 2024-03-25 |
Barrow Robert |
Chief Executive Officer |
Venta Informativa |
16,519 |
$9.50 |
$156.93K |
580,202 |
| 2024-03-25 |
Karlin Dan |
Chief Medical Officer |
Venta Informativa |
6,578 |
$9.50 |
$62.49K |
358,452 |
| 2024-02-27 |
Sullivan Mark |
Chief Legal Officer |
Concesión de RSU |
125,000 |
$4.98 |
$622.5K |
125,000 |
| 2024-02-27 |
Greenway Schond L. |
Chief Financial Officer |
Concesión de RSU |
150,000 |
$4.98 |
$747K |
150,000 |
| 2024-02-27 |
Barrow Robert |
Chief Executive Officer |
Concesión de RSU |
400,000 |
$4.98 |
$1.99M |
400,000 |
| 2024-02-27 |
Wernli Miri Halperin |
Executive President |
Concesión de RSU |
125,000 |
$4.98 |
$622.5K |
125,000 |
| 2024-02-27 |
Karlin Dan |
Chief Medical Officer |
Concesión de RSU |
150,000 |
$4.98 |
$747K |
150,000 |
| 2024-02-27 |
Liao Carrie |
Chief Accounting Officer |
Concesión de RSU |
100,000 |
$4.98 |
$498K |
100,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
